Search
for
Sort by
Research 31–60 of 240
- Bimatoprost for the management of vitiligo: A systematic review and meta‐analysis
- A Systematic Review of Case Series and Clinical Trials Investigating Regenerative Medicine for the Treatment of Vitiligo
- Impact of Fitzpatrick skin type on narrowband UVB therapy outcomes in cutaneous T-cell lymphoma: A retrospective analysis
- Current best evidence in pigmentary dermatology
- Lasers in the management of alopecia: a review of established therapies and advances in treatment
- 465 Multicenter prospective study on the efficacy of narrowband ultraviolet B treatment and its effect on quality of life, anxiety, depression in plaque psoriasis patients
- Evaluation of the Effect of Low Level Laser Therapy in the Treatment of Stable Vitiligo
- Expression of WNT1 signalling proteins after phototherapy exposure in vitiligo
- 8. Pathology
- 6. Phototherapy, Photomedicine, and Pigmentary Disorders
- 13. Wound Healing & Hair
- Trichoscopy in Unveiling the Triad of Netherton Syndrome
- Abstracts from the 2009 Annual Meeting of the Society for Pediatric Dermatology
- 11. Psoriasis/Acne and Disorders of Keratinization
- Prolonged Drug-Induced Hypersensitivity Syndrome/DRESS With Alopecia Areata and Autoimmune Thyroiditis
- 9. Immunology
- 5. HIV, Fungal and Infectious Diseases
- 4. Bullous/Mucous Membrane
- 1. Medical Practice; Therapy; Adverse Reactions
- Витамин D и патология кожи
- RASopathic alopecia: Hair changes associated with vemurafenib therapy
- Hypopigmented Mycosis Fungoides Treated with 308 nm Excimer Laser
- Dermatologic Adverse Events from Cancer Treatments
- Superficial Cryotherapy Versus Intralesional Corticosteroid Injection In Alopecia Areata: A Comparative Clinical And Dermoscopic Study
- Micro-Injury Induces Hair Regeneration and Vitiligo Repigmentation Through Wnt/ β-Catenin Pathway
- Transplantation of melanocyte stem cells in vitiliginous skin
- The Editor's Choice
- Alopecia areata: An update
- Dermatosurgical techniques for repigmentation of vitiligo
- Tofacitinib for the treatment of alopecia areata in preadolescent children